Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Albert Prats-Uribe and David Vizcaya.
Albert Prats-Uribe
Connection Strength
0.529
David Vizcaya
  1. Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. BMJ. 2021 05 11; 373:n1038.
    View in: PubMed
    Score: 0.236
  2. COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology (Oxford). 2021 10 09; 60(SI):SI37-SI50.
    View in: PubMed
    Score: 0.061
  3. Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Rheumatology (Oxford). 2021 07 01; 60(7):3222-3234.
    View in: PubMed
    Score: 0.060
  4. Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience. Pediatrics. 2021 09; 148(3).
    View in: PubMed
    Score: 0.059
  5. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun. 2020 10 06; 11(1):5009.
    View in: PubMed
    Score: 0.057
  6. Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol. 2020 Nov; 2(11):e698-e711.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.